An unusual glitch occurred this week on Google Inc (NASDAQ GOOG)’s image search engine that had tongues wagging from Twitter to Reddit. When users would search for an image, the same result of a Russian accident would display. This morning when someone searched for an image – any image – what popped up on screen…
A new study suggests that many consumers remain cautious about the prospect of purchasing or using digital currency. The report was written by the Massachusetts Division of Banks (MDB) in conjunction with the Conference of State Bank Supervisors (CSBS), who canvassed more than 1,000 consumers with an online survey that focused on digital currency. The…
Indigo analyst N. Landell-Mills is impressed with the latest results from Facebook Inc (NASDAQ FB) and Google Inc (NASDAQ GOOG), as each have managed to keep revenue growth high in competitive market segments, but that doesn’t mean he thinks that either company is an attractive investment. He expects the combination of slowing growth and the…
Apple Inc (NASDAQ AAPL) is expected to unveil the much-anticipated iPhone 6 at an event on Sept. 9, and analysts have been expecting great things for the company’s stock. They say that this time, shares won’t fall after the announcement. Instead, many believe the exact opposite thing will happen. Analysts believe that with the iPhone…
Kite Pharma, Inc (KITE) announced the publication of positive results from an ongoing phase I-IIa study on KTE-C19 in patients suffering from aggressive non-Hodgkin’s lymphoma in the Aug 25, 2014 issue of the American Society of Clinical Oncology’s Journal of Clinical Oncology. In the phase I-II study, KTE-C19 achieved 92% overall objective response rate. According…
Shares of Amicus Therapeutics (FOLD) soared 20.4% after the company announced positive data from its second phase III study (Study 012) on the oral small molecule chaperone migalastat HCl in Fabry patients with amenable mutations. The phase III study is evaluating the use of oral migalastat to standard-of-care enzyme replacement therapies (ERTs) − Sanofi’s (SNY)…
